Latest Checkpoint Capital L.P. Stock Portfolio
Checkpoint Capital L.P. Performance:
2025 Q1: -3.92%YTD: -3.92%2024: 4.12%
Performance for 2025 Q1 is -3.92%, and YTD is -3.92%, and 2024 is 4.12%.
About Checkpoint Capital L.P. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Checkpoint Capital L.P. reported an equity portfolio of $182.3 Millions as of 31 Mar, 2025.
The top stock holdings of Checkpoint Capital L.P. are , RYTM, RVMD. The fund has invested 37.3% of it's portfolio in ARGENX SE and 26.4% of portfolio in RHYTHM PHARMACEUTICALS INC.
The fund managers got completely rid off PHATHOM PHARMACEUTICALS INC (PHAT), AXSOME THERAPEUTICS INC (AXSM) and AVADEL PHARMACEUTICALS PLC stocks. They significantly reduced their stock positions in CIDARA THERAPEUTICS INC (CDTX). Checkpoint Capital L.P. opened new stock positions in PROTAGONIST THERAPEUTICS INC (PTGX), SEPTERNA INC and CORCEPT THERAPEUTICS INC (CORT). The fund showed a lot of confidence in some stocks as they added substantially to SOLENO THERAPEUTICS INC (SLNO), STOKE THERAPEUTICS INC (STOK) and REVOLUTION MEDICINES INC (RVMD).
The top stock holdings of Checkpoint Capital L.P. are , RYTM, RVMD. The fund has invested 37.3% of it's portfolio in ARGENX SE and 26.4% of portfolio in RHYTHM PHARMACEUTICALS INC.
The fund managers got completely rid off PHATHOM PHARMACEUTICALS INC (PHAT), AXSOME THERAPEUTICS INC (AXSM) and AVADEL PHARMACEUTICALS PLC stocks. They significantly reduced their stock positions in CIDARA THERAPEUTICS INC (CDTX). Checkpoint Capital L.P. opened new stock positions in PROTAGONIST THERAPEUTICS INC (PTGX), SEPTERNA INC and CORCEPT THERAPEUTICS INC (CORT). The fund showed a lot of confidence in some stocks as they added substantially to SOLENO THERAPEUTICS INC (SLNO), STOKE THERAPEUTICS INC (STOK) and REVOLUTION MEDICINES INC (RVMD).
Checkpoint Capital L.P. Annual Return Estimates Vs S&P 500
Our best estimate is that Checkpoint Capital L.P. made a return of -3.92% in the last quarter. In trailing 12 months, it's portfolio return was 0.31%.
New Buys
| Ticker | $ Bought |
|---|---|
| protagonist therapeutics inc | 8,471,900 |
| septerna inc | 4,776,040 |
| corcept therapeutics inc | 571,100 |
| immunocore hldgs plc | 267,356 |
| rapt therapeutics inc | 133,993 |
New stocks bought by Checkpoint Capital L.P.
Additions
| Ticker | % Inc. |
|---|---|
| soleno therapeutics inc | 146 |
| stoke therapeutics inc | 139 |
| revolution medicines inc | 86.67 |
| kymera therapeutics inc | 76.18 |
| disc medicine inc | 31.52 |
| rhythm pharmaceuticals inc | 24.62 |
| argenx se | 24.32 |
| tscan therapeutics inc | 14.9 |
Additions to existing portfolio by Checkpoint Capital L.P.
Reductions
| Ticker | % Reduced |
|---|---|
| cidara therapeutics inc | -47.00 |
Checkpoint Capital L.P. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| phathom pharmaceuticals inc | -18,466,200 |
| trevi therapeutics inc | -4,466,640 |
| avadel pharmaceuticals plc | -10,560,300 |
| pliant therapeutics inc | -7,052,460 |
| atyr pharma inc | -1,565,870 |
| axsome therapeutics inc | -14,787,200 |
| cytokinetics inc | -940,800 |
Checkpoint Capital L.P. got rid off the above stocks
Sector Distribution
Checkpoint Capital L.P. has about 53.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 53.4 |
| Others | 46.6 |
Market Cap. Distribution
Checkpoint Capital L.P. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 46.7 |
| MID-CAP | 41 |
| SMALL-CAP | 11 |
| MICRO-CAP | 1.3 |
Stocks belong to which Index?
About 43.7% of the stocks held by Checkpoint Capital L.P. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 56.3 |
| RUSSELL 2000 | 43.7 |
Checkpoint Capital L.P. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Checkpoint Capital L.P.
Checkpoint Capital L.P. has 14 stocks in it's portfolio. About 98.2% of the portfolio is in top 10 stocks. TCRX proved to be the most loss making stock for the portfolio. SLNO was the most profitable stock for Checkpoint Capital L.P. last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| argenx se | 37.34 | 115,000 | 68,064,500 | added | 24.32 | |||
| RYTM | rhythm pharmaceuticals inc | 26.37 | 907,240 | 48,056,500 | added | 24.62 | ||
| RVMD | revolution medicines inc | 7.61 | 392,011 | 13,861,500 | added | 86.67 | ||
| SLNO | soleno therapeutics inc | 6.78 | 172,902 | 12,353,800 | added | 146 | ||
| disc medicine inc | 6.63 | 243,311 | 12,078,000 | added | 31.52 | |||
| PTGX | protagonist therapeutics inc | 4.65 | 175,184 | 8,471,900 | new | |||
| STOK | stoke therapeutics inc | 2.67 | 730,717 | 4,859,270 | added | 139 | ||
| septerna inc | 2.62 | 824,878 | 4,776,040 | new | ||||
| KYMR | kymera therapeutics inc | 2.05 | 136,605 | 3,738,880 | added | 76.18 | ||
| TCRX | tscan therapeutics inc | 1.53 | 2,017,650 | 2,784,360 | added | 14.9 | ||
| CDTX | cidara therapeutics inc | 1.23 | 104,380 | 2,248,340 | reduced | -47.00 | ||
| CORT | corcept therapeutics inc | 0.31 | 5,000 | 571,100 | new | |||
| IMCR | immunocore hldgs plc | 0.15 | 9,011 | 267,356 | new | |||
| RAPT | rapt therapeutics inc | 0.07 | 109,830 | 133,993 | new | |||
| avadel pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | |||
| TRVI | trevi therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PLRX | pliant therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PHAT | phathom pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
